LLY stock news
This page provides real-time market news, earnings updates, and company announcements related to Eli Lilly and Company (LLY).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-05 14:11 EST
Options Traders Pick Sides on Centessa as Lilly’s $38 Bid Turns Binary
101 finance2026-04-02 07:15:34
Eli Lilly’s 2026 Guidance Acceleration Signals Growth Engine Still Roaring
101 finance2026-04-02 10:10:05
Goldman Sachs: Early Approval of Eli Lilly's Oral Weight-Loss Drug Will Usher in a New Growth Cycle
格隆汇2026-04-02 11:19:35
Lilly’s Oral Pill Debut: The $94.3B Sales Goal Is Already Reflected—Yet Zero Tolerance for Mistakes
101 finance2026-04-02 11:51:43
Prediction: This Will Be Eli Lilly's Next Billion-Dollar Growth Driver. (Hint: It's Not Weight Loss Drugs.)
101 finance2026-04-02 12:00:12
Company Updates on April 2, 2026
101 finance2026-04-02 14:34:01
Lilly's Foundayo: The $2.8B Revenue Flow and Price War Battle
101 finance2026-04-02 15:09:58
Structure Therapeutics Jumps 9.5% as Obesity Drug Buzz and Institutional Moves Drive Unexpected Rally: What’s Behind the Rapid Rise?
101 finance2026-04-02 15:15:52
LLY Options Indicate Bullish Pattern at $1000 Call Following Robust Earnings and Key Strategic Actions: Trading Opportunities for April 2
101 finance2026-04-02 18:09:44
Zoetis Faces a Crisis of Growth Confidence—Could the Lower Valuation Signal a Potential Rebound?
101 finance2026-04-02 19:51:58
Alexandria Real Estate Equities, Inc. Named One of the Most Trustworthy Companies in America by Newsweek for Fourth Consecutive Year
Finviz2026-04-02 20:06:53
Top 20 Active U.S. Stocks in Overnight Trading: Volume and News Overview
101 finance2026-04-02 21:39:45
Novo Nordisk Maintains Leading Trading Position Even as Volume Falls, with Wegovy Results Enhancing Its Market Advantage
101 finance2026-04-02 22:52:02
Hims & Hers Slides as FDA Curbs GLP-1 Compounding, Drives Top Trading Volume
101 finance2026-04-02 23:09:55
Sangamo’s Shares Rebound Following ST-920 BLA Filing Story Despite Growing Financial Losses
101 finance2026-04-02 23:52:10
LMRI Drops 26% as Uncertain Outlook and Tariff Concerns Loom
101 finance2026-04-03 01:33:47
Trump’s Complete Drug Tariff Threat Pushes Pharmaceutical Companies Into a 120-Day Race to Relocate Production or Adjust Prices
101 finance2026-04-03 05:49:19
Lilly's Oral GLP-1 Without Restrictions May Challenge Novo's Early Advantage in the Obesity Sector
101 finance2026-04-03 07:06:50
Eli Lilly's LY4060874: The Market Accurately Valued a Low-Key Phase 1 Milestone—Attention Moves Toward Oral GLP-1 and Cancer Developments
101 finance2026-04-03 16:48:40
Regulatory Jitters Drag PBH.N Down 13.95% — What’s Next for Prestige?
101 finance2026-04-04 01:18:37
Foundayo’s Advantage: Transforming Behavioral Anxiety Into a Pill-Driven Engine for Growth
101 finance2026-04-04 10:30:44
Eli Lilly's introduction of its GLP-1 oral medication and the Medicare price limit present an instant trading opportunity, while Centessa's integration poses potential challenges.
101 finance2026-04-04 18:57:41
Eli Lilly - Possible Bullish Continuation Incoming ?
TradingView2026-04-04 19:18:17
The Vanguard ETF With the Second-Highest Returns in the Past Ten Years Is Undergoing a 5-to-1 Stock Split. Discover Why April Is an Excellent Time to Buy.
101 finance2026-04-04 19:45:48
Prediction: This Will Be Eli Lilly's Next Billion-Dollar Growth Driver. (Hint: It's Not Weight Loss Drugs.)
101 finance2026-04-02 12:00:12
Company Updates on April 2, 2026
101 finance2026-04-02 14:34:01
Lilly's Foundayo: The $2.8B Revenue Flow and Price War Battle
101 finance2026-04-02 15:09:58
Structure Therapeutics Jumps 9.5% as Obesity Drug Buzz and Institutional Moves Drive Unexpected Rally: What’s Behind the Rapid Rise?
101 finance2026-04-02 15:15:52
LLY Options Indicate Bullish Pattern at $1000 Call Following Robust Earnings and Key Strategic Actions: Trading Opportunities for April 2
101 finance2026-04-02 18:09:44
Zoetis Faces a Crisis of Growth Confidence—Could the Lower Valuation Signal a Potential Rebound?
101 finance2026-04-02 19:51:58
Alexandria Real Estate Equities, Inc. Named One of the Most Trustworthy Companies in America by Newsweek for Fourth Consecutive Year
Finviz2026-04-02 20:06:53
Top 20 Active U.S. Stocks in Overnight Trading: Volume and News Overview
101 finance2026-04-02 21:39:45
Novo Nordisk Maintains Leading Trading Position Even as Volume Falls, with Wegovy Results Enhancing Its Market Advantage
101 finance2026-04-02 22:52:02
Hims & Hers Slides as FDA Curbs GLP-1 Compounding, Drives Top Trading Volume
101 finance2026-04-02 23:09:55
Sangamo’s Shares Rebound Following ST-920 BLA Filing Story Despite Growing Financial Losses
101 finance2026-04-02 23:52:10
LMRI Drops 26% as Uncertain Outlook and Tariff Concerns Loom
101 finance2026-04-03 01:33:47
Trump’s Complete Drug Tariff Threat Pushes Pharmaceutical Companies Into a 120-Day Race to Relocate Production or Adjust Prices
101 finance2026-04-03 05:49:19
Lilly's Oral GLP-1 Without Restrictions May Challenge Novo's Early Advantage in the Obesity Sector
101 finance2026-04-03 07:06:50
Eli Lilly's LY4060874: The Market Accurately Valued a Low-Key Phase 1 Milestone—Attention Moves Toward Oral GLP-1 and Cancer Developments
101 finance2026-04-03 16:48:40
Regulatory Jitters Drag PBH.N Down 13.95% — What’s Next for Prestige?
101 finance2026-04-04 01:18:37
Foundayo’s Advantage: Transforming Behavioral Anxiety Into a Pill-Driven Engine for Growth
101 finance2026-04-04 10:30:44
Eli Lilly's introduction of its GLP-1 oral medication and the Medicare price limit present an instant trading opportunity, while Centessa's integration poses potential challenges.
101 finance2026-04-04 18:57:41
Eli Lilly - Possible Bullish Continuation Incoming ?
TradingView2026-04-04 19:18:17
The Vanguard ETF With the Second-Highest Returns in the Past Ten Years Is Undergoing a 5-to-1 Stock Split. Discover Why April Is an Excellent Time to Buy.
101 finance2026-04-04 19:45:48
LLY stock chart
LLY stock detailsLLY stock price change
On the last trading day, LLY stock closed at 935.58 USD, with a price change of -1.98% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more